Free Press Release Center Logo
   
  Home | About Us | Sample Press Release
  Press Release Articles | Press Releases and SEO | Press Release Book  
 

Victim and Mother Who Filed First Federal Paxil Birth Defect Trial Featured In Television News Story

The child at the center of Hayes v. Glaxo SmithKline was featured in a news story by News9 Oklahoma City.

PDF  View as PDF  Print View   

September 13, 2008 (FPRC) -- The child at the center of the first Paxil birth defect case filed in Oklahoma was profiled in a story by News 9, Oklahoma City, Oklahoma. The video may be viewed by going to http://DrugSettlement.com/drugs/paxil/facts .

Jennifer Hayes used the drug Paxil for depression while she was pregnant. Her son Kade was born with serious congenital heart deformities, pulmonary atresia and pulmonary stenosis. In order to save his life he underwent open heart surgery shortly after birth.

A lawsuit has been filed against Glaxo SmithKline, the manufacturer of Paxil. The case is currently pending before Judge Claire V. Eagan of the United States District Court for the Northern District of Oklahoma. The family is represented by Nix & McIntyre, LLP a law firm located in Oklahoma City.

The complaint alleges that Jennifer Hayes took Paxil pursuant to her physician's orders during the first trimester of her pregnancy. After an uneventful pregnancy the couple went to Jane Phillips Medical Center in their hometown to deliver the baby they would name K.H.

"At delivery, K.H.’s heart beat erratically. Because this is not uncommon, baby K.H. was initially transferred to the nursery for observation. A few hours later, a nurse heard a murmur and baby K.H.’s heart still did not function correctly. Within a few hours, baby K.H. was rushed by Life Flight to St. Francis Children’s Hospital in Tulsa, Oklahoma. Just a few hours after delivery, Jennifer checked out the hospital to be with her baby."

"At St. Francis, Jennifer Hayes’s and Justin Hayes’s hopes for a healthy baby were quickly dashed. Testing would reveal that baby K.H. suffered from severe pulmonic stenosis. His pulmonic valve was almost entirely closed. A heart catheterization the first day almost killed him. That same day, K.H. underwent his first open-heart surgery. A second surgery a few days later was required to cope with massive fluid build-up around his lungs. A third surgery the second week of life was required to pack down his right diaphragm. On Christmas Eve, K.H. suffered an IV infiltration in his right hand resulting in a severe burn. Debridement and a skin graft followed."

"In February of 2006, K.H. got pneumonia as a result of pulmonary hypertension caused by his weakened heart. A month stay in the hospital followed. After a brief return home, another hospitalization and heart catheterization followed."

"Baby K.H. spent the first seven months of his life on a ventilator. Three additional months were spent breathing through a tube in his throat."

The complaint which also seeks punitive damages alleges that SmithKline Beecham, now known as Glaxo SmithKline, is wholly responsible for the injuries sustained by the infant by their negligence "in its marketing, labeling, and promoting of Paxil."

In September of 2005, and again in December of 2005, GSK published some compilations of data concerning the epidemiological association or "signal" between Paxil and birth defects. The "relative risk," which is one barometer by which epidemiologists commonly measure the "strength" of an association, was 2.26. This constitutes more than a doubling of the risk of cardiac defects in infants exposed to Paxil during pregnancy.

Noble McIntyre of Nix & McIntyre, LLP, attorneys for the infant is currently representing about a dozen other children who have suffered similar injuries as result of exposure to Paxil.

If you or someone you know has had a child who suffers from any injury, birth defect one due to Paxil exposure during pregnancy you are not alone and you deserve answers. Contact the experienced, and knowledgeable DrugSettlement.com birth defect lawyers at http://DrugSettlement.com for more information.



Send an email to John McCaffrey of DrugSettlement.com, LLC
(631) 864-4420

Recent Press Releases By The Same User



Press releases by industry
Advertising
Aerospace and Defense
Architecture
Arts and Entertainment
Audio and Video
Automotive
Baseball
Basketball
Beauty
Beverages
Business
Chemicals
Christianity
Communication
Computers
Consumer
Crops
eCommerce
Economy
Education
Employment
Energy
Environment
Events and Trade Shows
Fashion
Finance
Food
Football
Forestry
Golf
Government
Hardware
Healthcare
Holidays
Human Resources
Immigration Services
Information Technology
Insurance
Internet
Investment Services
Legal
Leisure
Lifestyle
Linux and Open Source
Maritime
Media
Non-Profit
Photography
Plumbing and Heating
Politics
Public Relations
Railroads
Real Estate
Religion and Faith
Restaurants
Retail
Science
Society
Software
Sports
Technology
Television
Toys
Trade
Transportation
Travel and Tourism
Trucking
Volunteer
Waste Management
Water

[ Vist our sister sites: Linux news | Bible Study Tool ]

Site design and layout copyright 2005-2015 Free Press Release Center